MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1159/iaa/adfag030

Медицинская библиотека · International archives of allergy and immunology · 2026

Plasma miR-1 is downregulated in allergic rhinitis and alleviates IL-13-induced nasal epithelial inflammation via targeting BDNF.

Wang Jinyan, Wang Yang

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Allergic rhinitis (AR), a common chronic inflammatory disorder of the upper airway, currently lacks reliable non-invasive molecular biomarkers for dynamic disease monitoring and therapeutic guidance. This study aimed to evaluate the diagnostic value of plasma miR 1 in AR and to investigate its role in nasal epithelial inflammation and oxidative stress, along with the underlying molecular mechanism.

METHODS

Plasma miR 1 was quantified by RT qPCR in 118 AR patients and 100 healthy controls, followed by correlation analysis with disease severity indices. An IL 13-stimulated human nasal epithelial cell (HNEpC) model was employed to examine viability, apoptosis, pro-inflammatory cytokines (IL 6, IL 8), and oxidative stress markers (MDA, GSH) following miR 1 overexpression or knockdown. Bioinformatic screening and dual-luciferase reporter assays were utilized to identify and validate BDNF as a direct miR 1 target. Rescue experiments were performed through co-transfection of miR 1 mimic with BDNF overexpression vector.

RESULTS

Plasma miR 1 was significantly lower in AR patients and negatively correlated with TNSS and RQLQ scores, yielding an AUC of 0.864 for discriminating AR from controls. In IL 13 treated HNEpC, miR 1 overexpression enhanced cell viability, reduced apoptosis, decreased IL 6 and IL 8 secretion, and ameliorated oxidative stress (lowered MDA, elevated GSH). BDNF was confirmed as a direct target of miR 1. BDNF overexpression partially reversed the protective effects of miR 1 upregulation.

CONCLUSIONS

Plasma miR 1 is downregulated in AR and correlates with disease severity, suggesting its potential as a non invasive diagnostic biomarker. Experimental evidence indicates that miR 1 may alleviate IL 13 induced inflammation and oxidative stress in HNEpC through direct targeting of BDNF.

Для цитирования: Wang Jinyan, Wang Yang. Plasma miR-1 is downregulated in allergic rhinitis and alleviates IL-13-induced nasal epithelial inflammation via targeting BDNF.. International archives of allergy and immunology. 2026. DOI: 10.1159/iaa/adfag030.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.